Repair capacity and kinetics in spheroids from a lung metastasis of a human soft tissue sarcoma: a growth delay study.
Spheroids grown from the human cell line EF8 of a lung metastasis of a human malignant fibrous histiocytoma were given fractionated irradiation with 60Co gamma rays at passages 31 and 32. The mean diameter of the spheroids at the time of treatment was 250 microns. Growth delay was used as the end point in these studies. Two experiments were carried out to determine the capacity and kinetics of repair of sublethal damage. In the first experiment, one, two, and five fractions were given at three or four dose levels with fixed intervals of 360 min. In the second experiment, schedules with two and four dose fractions and intervals of 0, 20, 60, 120, and 360 min were used, each at two dose levels. Data analysis was performed by a direct method based on the alpha/beta model and first-order repair kinetics of radiation damage. In both experiments, the alpha/beta value of EF8 spheroids was estimated to be about 8 (6-10) Gy. The rate constant of repair, mu, and its 95% confidence interval were estimated to be 0.62 (0.40-0.84) 10(-2) min-1, equivalent to a half-time of repair (T1/2) of 112 (83-172) min. A more detailed analysis of the data of the second experiment revealed a significant dependence of the rate constant of repair, mu, on the total radiation effect induced by the fractionated radiation treatments with short overall times. With increasing level of effect, mu decreased. These data indicate that the half-time of recovery of a human tumor can be longer than that of the surrounding normal tissue, in this case lung, at least for a limited range of doses and for some fractionation schedules.
Stuschke
M
M
Department of Radiotherapy, University of Essen, Federal Republic of Germany.
Budach
V
V
Sack
H
H
Streffer
C
C
D003037:Cobalt Radioisotopes / Q000627:therapeutic use; D004260:DNA Repair / Q000528:radiation effects*; D005720:Gamma Rays; D018219:Histiocytoma, Benign Fibrous / Q000532:radiotherapy / Q000556:secondary*; D006801:Humans; D066298:In Vitro Techniques; D008175:Lung Neoplasms / Q000532:radiotherapy / Q000556:secondary*; D008954:Models, Biological; D012983:Soft Tissue Neoplasms / Q000532:radiotherapy*; D013997:Time Factors
D003037:Cobalt Radioisotopes